ESTIMATING THE COST EFFECTIVENESS OF VILDAGLIPTIN VERSUS SULPHONYLUREA IN COMBINATION WITH METFORMIN- CLINICAL GUIDELINES VERSUS CLINICAL PRACTICE

May 1, 2016, 00:00
10.1016/j.jval.2016.03.1293
https://www.valueinhealthjournal.com/article/S1098-3015(16)01361-9/fulltext
Title : ESTIMATING THE COST EFFECTIVENESS OF VILDAGLIPTIN VERSUS SULPHONYLUREA IN COMBINATION WITH METFORMIN- CLINICAL GUIDELINES VERSUS CLINICAL PRACTICE
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01361-9&doi=10.1016/j.jval.2016.03.1293
First page : A202
Section Title : Diabetes/Endocrine Disorders - Cost Studies
Open access? : No
Section Order : 637
Categories :
Tags :
Regions :
ViH Article Tags :